Cardiovascular prevention and international health: Time for action

European Journal of Preventive Cardiology

Volumn 18, Issue 4, 2011, Pages 547-549

  Browne, Joyce L ^a   Grobbee, Diederick E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; EDITORIAL; HEALTH CARE COST; HUMAN; MORTALITY; POVERTY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REHABILITATION CARE;

EID: 80054864363     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/1741826711414116     Document Type: Article

References (18)

1. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and cost of chronic disease in low-income and middle-income countries. Lancet 2007; 370: 1929–1938.
2. Beaglehole R, Horton R. Chronic disease: global action must match global evidence. Lancet 2011; 376: 1619–1621.
3. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 1971; 49: 509–538.
4. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular disease. Part I: General considerations, the epidemiologic transition, risk factors and impact of urbanisation. Circulation 2001; 104: 2746–2753.
5. UN. Millennium summit goals 2000; New York: United Nations.
6. Bill and Melinda Gates Foundation. Global Health Strategy Overview. 2010, http://www.gatesfoundation.org/global-health/Documents/global-health-strategy-overview.pdf accessed 16 February 2011.
7. Sen K, Bonita R. Global health status: two steps forward, one step back. Lancet 2000; 356: 577–582.
8. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet 2005; 366: 1578–1582.
9. Horton R. The neglected epidemic of chronic disease. Lancet 2005; 366: 1514–1514.
10. Horton R. Chronic disease: the case for urgent global action. Lancet 2007; 370: 1929–1938.
11. WHO. Preventing chronic disease: a vital investment: WHO global report. Geneva: World Health Organization, 2005.
12. Murray CJL, Lopez AD. Mortality by cause of eight regions in the world: Global Burden of Disease Study. Lancet 1997; 349: 1269–1276.
13. WHO. Fact sheet – The top ten causes of death. http://www.who.int/mediacentre/factsheets/fs310_2008.pdf accessed 17 February 2011.
14. Fuster V, Voute J, Hunn M, Smith SC Jr. Low priority of cardiovascular and chronic disease on the global health agenda – a cause for concern. Circulation 2007; 116: 1966–1970.
15. Leeder S, Raymond S, Greenberg H, Liu H. A race against time: the challenge of cardiovascular disease in developing economies 2004; New York: The Earth Institute, Columbia University.
16. Alwan A, MacLean DR, Riley LM, Tursan d’Espaignet E, Mathers CD, Stevens GA, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 2010; 376: 1861–1868.
17. Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007; 370: 2054–2062.
18. Asria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007; 370: 2054–2062.